Two Sigma Advisers’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-356,700
| Closed | -$17.3M | – | 124 |
|
|
2025
Q4 | $17.3M | Sell |
356,700
-17,000
| -5% | -$663K | 0.03% | 389 |
|
|
2025
Q3 | $11.4M | Buy |
373,700
+83,300
| +29% | +$1.91M | 0.02% | 459 |
|
|
2025
Q2 | $6.45M | Buy |
290,400
+22,300
| +8% | +$467K | 0.01% | 653 |
|
|
2025
Q1 | $4.98M | Sell |
268,100
-25,200
| -9% | -$420K | 0.01% | 794 |
|
|
2024
Q4 | $3.88M | Buy |
293,300
+107,800
| +58% | +$2.61M | 0.01% | 821 |
|
|
2024
Q3 | $6.21M | Buy |
185,500
+63,100
| +52% | +$2.16M | 0.01% | 642 |
|
|
2024
Q2 | $3.07M | Sell |
122,400
-9,300
| -7% | -$217K | 0.01% | 974 |
|
|
2024
Q1 | $2.97M | Buy |
131,700
+32,500
| +33% | +$770K | 0.01% | 1020 |
|
|
2023
Q4 | $2.12M | Sell |
99,200
-17,900
| -15% | -$309K | 0.01% | 1254 |
|
|
2023
Q3 | $2.1M | Sell |
117,100
-8,900
| -7% | -$170K | 0.01% | 1175 |
|
|
2023
Q2 | $2.56M | Buy |
126,000
+57,100
| +83% | +$1.16M | 0.01% | 1064 |
|
|
2023
Q1 | $1.5M | Sell |
68,900
-17,900
| -21% | -$435K | ﹤0.01% | 1428 |
|
|
2022
Q4 | $2.69M | Buy |
86,800
+30,500
| +54% | +$861K | 0.01% | 1077 |
|
|
2022
Q3 | $1.44M | Sell |
56,300
-5,000
| -8% | -$117K | ﹤0.01% | 1344 |
|
|
2022
Q2 | $1.24M | Sell |
61,300
-16,100
| -21% | -$357K | ﹤0.01% | 1469 |
|
|
2022
Q1 | $1.92M | Sell |
77,400
-48,100
| -38% | -$1.46M | 0.01% | 1281 |
|
|
2021
Q4 | $4.36M | Sell |
125,500
-44,400
| -26% | -$1.41M | 0.01% | 826 |
|
|
2021
Q3 | $4.61M | Sell |
169,900
-99,100
| -37% | -$2.52M | 0.01% | 824 |
|
|
2021
Q2 | $6.97M | Sell |
269,000
-145,700
| -35% | -$3.49M | 0.02% | 706 |
|
|
2021
Q1 | $8.94M | Buy |
414,700
+29,800
| +8% | +$752K | 0.02% | 624 |
|
|
2020
Q4 | $8.28M | Buy |
384,900
+107,000
| +39% | +$2.6M | 0.02% | 639 |
|
|
2020
Q3 | $4.1M | Sell |
277,900
-130,600
| -32% | -$2.36M | 0.01% | 836 |
|
|
2020
Q2 | $9.13M | Buy |
408,500
+8,500
| +2% | +$155K | 0.03% | 587 |
|
|
2020
Q1 | $5.65M | Buy |
400,000
+138,100
| +53% | +$2.09M | 0.02% | 668 |
|
|
2019
Q4 | $4.26M | Buy |
261,900
+210,700
| +412% | +$4.98M | 0.01% | 906 |
|
|
2019
Q3 | $1.79M | Buy |
51,200
+5,400
| +12% | +$257K | ﹤0.01% | 1158 |
|
|
2019
Q2 | $2.58M | Buy |
45,800
+6,100
| +15% | +$439K | 0.01% | 1101 |
|
|
2019
Q1 | $2.9M | Sell |
39,700
-9,700
| -20% | -$670K | 0.01% | 1063 |
|
|
2018
Q4 | $3.15M | Sell |
49,400
-11,700
| -19% | -$870K | 0.01% | 981 |
|
|
2018
Q3 | $6.1M | Buy |
61,100
+14,000
| +30% | +$1.16M | 0.01% | 755 |
|
|
2018
Q2 | $3.35M | Buy |
47,100
+43,700
| +1,285% | +$3.67M | 0.01% | 1051 |
|
|
2018
Q1 | $354K | Buy |
+3,400
| New | +$383K | ﹤0.01% | 1953 |
|
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
